drugset / Trial / NCT01637077

Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel

NCT01637077

Phase 2 Completed 46 enrolled Academic and Community Cancer Research United
RandomizedParallel-groupDouble-blindSupportive care

Summary

This randomized pilot clinical trial studies pregabalin in preventing acute pain syndrome in patients receiving paclitaxel. Pregabalin may control the pain caused by cancer treatment.

Timeline

Start
2012-01
Primary completion
2013-11
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule Oral

Indications